Low dose of dexmedetomidine as an adjuvant to bupivacaine in cesarean surgery provides better intraoperative somato-visceral sensory block characteristics and postoperative analgesia
- PMID: 28969013
- PMCID: PMC5609945
- DOI: 10.18632/oncotarget.18864
Low dose of dexmedetomidine as an adjuvant to bupivacaine in cesarean surgery provides better intraoperative somato-visceral sensory block characteristics and postoperative analgesia
Abstract
Object: In this study, we aimed to investigate the beneficial effects of dexmedetomidine on somato-visceral sensory block characteristcs, postoperative analgesia and stress response of intrathecal bupivacaine administration in women undergoing cesarean section, and to find out which dose is better.
Methods: Sixty parturients with the American Society of Anesthesiologists (ASA) physical status I or II were anesthetized with intrathecal bupivacaine(10mg) alone or in combination with dexmedetomidine (3 μg and 5 μg) to undergo cesarean section. The anesthetic parameters, postoperative analgesia and stress responses were monitored.
Results: Co-administration of dexmedetomidine(3 μg and 5 μg) prolonged the duration of motor and sensory block compared with bupivacaine(10mg) alone. Less supplemental dose of lidocaine and fentanyl were required in dexmedetomidine(3 μg and 5 μg) co-administration groups. Visceral traction response and abdominal muscle relaxation in operation were better in dexmedetomidine(3 μg and 5 μg) co-administration groups. No difference in haemodynamics was detected among groups. There was no significant difference in Apgar scores, neonatal umbilical pH, oxygen pressure, carbon dioxide pressure and lactate level among groups. Postoperative plasma IL-6 and cortisol levels were lower in dexmedetomidine(3 μg and 5 μg) co-administration groups. At 6 hour after operation the visual analogue scale (VAS) was smaller in dexmedetomidine(3 μg and 5 μg) co-administration groups. The uterine contraction pain at 6 and 12 hour after operation and supplemental analgesics had no difference across three groups. No difference of side effects(shivering, nausea and vomiting, itching), the first anal aerofluxus time and intraoperation tramadol dose were detected among the three groups.
Conclusion: The use of dexmedetomidine especially at the dose of 3μg as an adjuvant to bupivacaine in cesarean surgery provides better intraoperative somato-visceral sensory block characteristcs and postoperative analgesia, which produced no influence on Apgar scores, side effects and stress response.
Keywords: cesarean surgery; dexmedetomidine; postoperative analgesia; somato-visceral sensory block.
Conflict of interest statement
CONFLICTS OF INTEREST The authors declare no conflicts of interest.
Figures
Similar articles
-
Effect of Different Doses of Intrathecal Dexmedetomidine as an Adjuvant Combined With Hyperbaric Ropivacaine in Patients Undergoing Cesarean Section.Front Pharmacol. 2020 Mar 20;11:342. doi: 10.3389/fphar.2020.00342. eCollection 2020. Front Pharmacol. 2020. PMID: 32265713 Free PMC article.
-
Comparative Evaluation of Intrathecal Bupivacaine Alone, Bupivacaine-fentanyl, and Bupivacaine-dexmedetomidine in Caesarean Section.Drug Res (Stuttg). 2015 Sep;65(9):468-72. doi: 10.1055/s-0034-1387740. Epub 2014 Sep 10. Drug Res (Stuttg). 2015. PMID: 25207707 Clinical Trial.
-
Intrathecal Dexmedetomidine Combined With Ropivacaine in Cesarean Section: A Prospective Randomized Double-Blind Controlled Study.Front Med (Lausanne). 2022 Jul 7;9:922611. doi: 10.3389/fmed.2022.922611. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35872755 Free PMC article.
-
Comparison of caudal bupivacaine alone with bupivacaine plus two doses of dexmedetomidine for postoperative analgesia in pediatric patients undergoing infra-umbilical surgery: a randomized controlled double-blinded study.Paediatr Anaesth. 2015 Sep;25(9):883-90. doi: 10.1111/pan.12686. Epub 2015 Jun 1. Paediatr Anaesth. 2015. PMID: 26033312 Clinical Trial.
-
A Systematic Review and Meta-analysis of Efficacy and Safety of Dexmedetomidine Combined With Intrathecal Bupivacaine Compared to Placebo.Cureus. 2022 Dec 12;14(12):e32425. doi: 10.7759/cureus.32425. eCollection 2022 Dec. Cureus. 2022. PMID: 36644042 Free PMC article. Review.
Cited by
-
Comparative evaluation of intrathecal bupivacaine alone and bupivacaine combined with dexmedetomidine in cesarean section using spinal anesthesia: a meta-analysis.J Int Med Res. 2019 Jul;47(7):2785-2799. doi: 10.1177/0300060518797000. Epub 2019 Jun 17. J Int Med Res. 2019. PMID: 31204535 Free PMC article.
-
The effect of adding dexmedetomidine or dexamethasone to bupivacaine-fentanyl mixture in spinal anesthesia for cesarean section.J Anaesthesiol Clin Pharmacol. 2024 Jan-Mar;40(1):82-89. doi: 10.4103/joacp.joacp_396_22. Epub 2024 Mar 14. J Anaesthesiol Clin Pharmacol. 2024. PMID: 38666154 Free PMC article.
-
Dexmedetomidine as an adjuvant for single spinal anesthesia in patients undergoing cesarean section: a system review and meta-analysis.J Int Med Res. 2020 May;48(5):300060520913423. doi: 10.1177/0300060520913423. J Int Med Res. 2020. PMID: 32466699 Free PMC article.
-
Effect of different doses of epidural dexmedetomidine on reducing visceral traction reaction for cesarean section: a double-blind randomized controlled trial.J Anesth. 2023 Jun;37(3):371-378. doi: 10.1007/s00540-023-03166-8. Epub 2023 Jan 24. J Anesth. 2023. PMID: 36692824 Clinical Trial.
-
Analgesic Characteristics of Bupivacaine Alone and in Combination with Dexmedetomidine or Meperidine in Spinal Anesthesia during Cesarean Section: A Double-Blind Randomized Clinical Trial Study.Pain Res Manag. 2022 Jul 18;2022:5111214. doi: 10.1155/2022/5111214. eCollection 2022. Pain Res Manag. 2022. PMID: 35899020 Free PMC article. Clinical Trial.
References
-
- Sapate M, Sahu P, Thatte WS, Dubey R. A randomized, double blind, control study of the effects of adding nalbuphine to spinal bupivacaine for lower abdominal surgeries in elderly patients. Anaesth Pain & Intensive Care. 2013;17:145–148.
LinkOut - more resources
Full Text Sources
Other Literature Sources